We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

32 hedge funds and large institutions have $25.1M invested in Biolase, Inc. in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less funds holding

Funds holding: 34 → 32 (-2)

48% less capital invested

Capital invested by funds: $48.1M → $25.1M (-$23M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
32
Holders Change
-2
Holders Change %
-5.88%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
6
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$725K
2
VKH
Virtu KCG Holdings
New York
+$37.2K
3
Goldman Sachs
Goldman Sachs
New York
+$18.6K
4
Northern Trust
Northern Trust
Illinois
+$18.6K
5
WS
Wedbush Securities
California
+$18.6K

Top Sellers

Rank Fund Capital Flow
1
Bank of New York Mellon
Bank of New York Mellon
New York
-$130K
2
Stifel Financial
Stifel Financial
Missouri
-$112K
3
QSS
Quantitative Systematic Strategies
Florida
-$105K
4
Boston Partners
Boston Partners
Massachusetts
-$92.9K
5
PPA
Parametric Portfolio Associates
Washington
-$45K
Name Holding Trade Value Shares
Change 		Change in
Stake
Stifel Financial
26
Stifel Financial
Missouri
$24K -$112K -6 -75%
State Street
27
State Street
Massachusetts
$16K – – –
T. Rowe Price Associates
28
T. Rowe Price Associates
Maryland
$16K – – –
Dimensional Fund Advisors
29
Dimensional Fund Advisors
Texas
$15K – – –
KF
30
Krilogy Financial
Missouri
$13K – – –
BA
31
BlackRock Advisors
Delaware
$10K – – –
WS
32
Wedbush Securities
California
$9K +$18.6K +1 New
BIM
33
BlackRock Investment Management
Delaware
$7K – – –
UBS Group
34
UBS Group
Switzerland
$3K – – –
Bank of America
35
Bank of America
North Carolina
$2K – – –
MAM
36
Meeder Asset Management
Ohio
$2K – – –
PNC Financial Services Group
37
PNC Financial Services Group
Pennsylvania
$2K – – –
Creative Planning
38
Creative Planning
Kansas
$1K – – –
JFA
39
JNBA Financial Advisors
Minnesota
$1K – – –
LTFS
40
Ladenburg Thalmann Financial Services
Florida
$1K – – –
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –
QSS
42
Quantitative Systematic Strategies
Florida
– -$105K -5 Closed
PPA
43
Parametric Portfolio Associates
Washington
– -$45K -2 Closed
Citadel Advisors
44
Citadel Advisors
Florida
– -$22K -1 Closed
Wells Fargo
45
Wells Fargo
California
– -$18.6K -1 Closed
TRCT
46
Tower Research Capital (TRC)
New York
– -$1K – –
1
2

BIOL Hedge Fund Activity: Q3 2015 in Review

32 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q3 2015, worth a combined $25.1M — down 48% from $48.1M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BIOL and 2 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 3 added.

The largest buyer was Consonance Capital Management, adding an estimated $725K. The largest seller was Bank of New York Mellon, cutting an estimated $130K.

  • 32 institutional investors held Biolase, Inc. (BIOL) as of Q3 2015, down from 34 in Q2 2015.
  • Funds reported $25.1M of Biolase, Inc. stock for Q3 2015, down 48% quarter-over-quarter.
  • 2 funds opened new Biolase, Inc. positions in Q3 2015 and 4 closed out, a net change of -2 holders.
  • The largest Biolase, Inc. buyer in Q3 2015 was Consonance Capital Management, an estimated $725K added.
  • The largest Biolase, Inc. seller in Q3 2015 was Bank of New York Mellon, an estimated $130K sold.

Based on aggregated 13F filings for Q3 2015.